Syndromic Sensorineural Hearing Loss Treatment & Management
- Author: Stephanie A Moody Antonio, MD; Chief Editor: Arlen D Meyers, MD, MBA more...
See the list below:
- Medical therapy: Treat any middle ear disease, including otitis media, with the appropriate medical therapy.
- The goal of amplification is to use any residual hearing to at least orient patients to surrounding environments. Hearing amplification can generally be implemented successfully during the first 6 weeks of life.
- Available hearing amplification devices include conventional analog hearing aids, digital hearing aids, bone conduction hearing aids, and bone-anchored hearing aids. Other middle and inner ear implantable devices are undergoing clinical trials.
- Assistive listening devices and personal systems
- Personal devices, such as FM trainers, aid in reducing the signal-to-noise ratio in various listening situations with significant background noise, eg, classrooms.
- Telephone devices can include such items as volume controls and couplers for use with certain hearing aids, along with telecommunication devices for deaf persons who are unable to use standard telephones.
- Closed captioning allows television use for individuals who are severely hearing impaired.
- Signaling devices substitute visual signals for auditory signals. They can detect environmental sounds, such as doorbells, telephones, alarm clocks, fire alarms, or crying babies.
Surgical management of external and middle ear deformities can be recommended for bilateral hearing loss and some unilateral cases.
- Cochlear implantation
- Cochlear implants are electronic devices designed to convert mechanical sound energy into electric signals that can be delivered to the cochlear nerve.
- Consider cochlear implantation for patients who do not significantly benefit from conventional hearing amplification.
- To preoperatively ensure the presence of an intact cochlear nerve, consider MRI. CT scan of the temporal bones is routinely performed to identify cochlear abnormalities.
- Children younger than 5 years who have restored auditory input via cochlear implantation achieve substantially better language skills. Cochlear implantation may be performed at age 1 year.
See the list below:
- Geneticists may offer assistance in establishing the etiology of SNHL.
- Geneticists also provide genetic counseling to address a family's questions about the etiology of the patient's hearing loss and the risk of recurrence for future children.
- Audiologists assist in selecting the most appropriate hearing aid for the patient. Selection of the appropriate aid is critical and is usually the responsibility of the audiologist.
- Systematic monitoring is necessary to ensure proper function of the device while monitoring speech and language development.
- Speech and language pathologist
- Patients' linguistic and communicative skills must be analyzed while understanding that language capability, and not the hearing level, is the final indication of a successful habilitative program.
- Normally, language should first be presented to children who are hearing impaired through all available inputs, including auditory, visual, and tactile stimuli.
- Ophthalmologist: Consider consultation to assess visual acuity and to evaluate any possible ocular components of syndromic hearing loss.
Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci. 2007 Mar. 64(5):566-80. [Medline].
Mehra S, Eavey RD, Keamy DG Jr. The epidemiology of hearing impairment in the United States: newborns, children, and adolescents. Otolaryngol Head Neck Surg. 2009 Apr. 140(4):461-72. [Medline].
Morzaria S, Westerberg BD, Kozak FK. Systematic review of the etiology of bilateral sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol. 2004 Sep. 68(9):1193-8. [Medline].
Saunders JE, Vaz S, Greinwald JH, Lai J, Morin L, Mojica K. Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope. 2007 Mar. 117(3):387-98. [Medline].
Huang BY, Zdanski C, Castillo M. Pediatric sensorineural hearing loss, part 2: syndromic and acquired causes. AJNR Am J Neuroradiol. 2012 Mar. 33(3):399-406. [Medline].
Information on Hearing Loss - Ten Syndromes Most Commonly Associated With Hearing Impairment. boystownhospital.org. Available at http://boystownhospital.org/Hearing/info/genetics/syndromes/ten.asp. Accessed: April 14, 2009.
Song J, Feng Y, Acke FR, Coucke P, Vleminckx K, Dhooge IJ. Hearing loss in Waardenburg syndrome: a systematic review. Clin Genet. 2015 Jun 22. [Medline].
Usher Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=ushersyndrome. Accessed: April 14, 2009.
Pendred Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=pendredsyndrome. Accessed: April 14, 2009.
Jervell and Lange-Nielson Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=jervellandlangenielsensyndrome. Accessed: April 14, 2009.
Cockayne Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=cockaynesyndrome.
Alstrom Disease. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=alstromsyndrome. Accessed: April 14, 2009.
Nadol JB Jr, Marshall JD, Bronson RT. Histopathology of the human inner ear in Alstrom's syndrome. Audiol Neurootol. 2015. 20 (4):267-72. [Medline].
Merchant SN, Burgess BJ, Adams JC, Kashtan CE, Gregory MC, Santi PA. Temporal bone histopathology in alport syndrome. Laryngoscope. 2004 Sep. 114(9):1609-18. [Medline].
Norrie Disease. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=norriedisease. Accessed: April 14, 2009.
FDA approves first implantable hearing device for adults with a certain kind of hearing loss. US Food and Drug Administration. March 20, 2014. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm389860.htm.
Alport Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=alportsyndrome. Accessed: April 14, 2009.
Alstrom CH. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous disease. Acta Psychiatrica Scandinavica. 1959. 34:1-35.
Cockayne E. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1936. 2:1.
Jervell A, Lange-Nielsen J. Congenital deaf-mutism functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957. 54:9-68.
National Newborn Screening Status ReportUpdated 03/11/09. Available at http://genes-r-us.uthscsa.edu/nbsdisorders.pdf.
Ouyang SM, Yan D, Yuan HJ, et al. The genetic basis of non-syndromic hearing loss among Chinese. Journal Human Genetics. 2009. 54(3):131-40.
Refsum S. Heredopathia actica polyneuritis formis. Acta Psychiatrica Scandinavica. 1946. 38:301-303.
Strome M. Down's syndrome: a modern otorhinolaryngological perspective. Laryngology. 1959. 69:54-89.
Usher CH. On the inheritance of retinitis pigmentosa, with notes of a case. London Ophthalmol Hosp Nep. 1914. 19:130-136.
Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows, and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Gen. 1951. 3:195-253.